Home
About us
Team
Companies
Stories
ESG
News
Contact
Press Release
Keensight Capital invests in Biovian, a leading biopharmaceutical contract development and manufacturing organization (CDmO)
By
WeAreBlow
May 23, 2018
February 1st, 2019
No Comments
Download
Télécharger
Previous Post
Theodor Wuppermann joins Keensight Capital as Associate Director
Next Post
PIXID continues European expansion with acquisition of Dutch staffing CRM supplier Carerix
Home
About us
Team
Companies
Stories
ESG
News
Contact
